Urinary incontinence (UI) and overactive bladder (OAB) are more common adverse health outcomes in patients who have ...
Routine use of urodynamic testing for overactive bladder (OAB) did not improve patient-reported outcomes when combined with comprehensive clinical assessment (CCA), a large randomized trial showed.
CLEVELAND, Ohio — Urinary incontinence affects millions of older Americans but is likely underreported, according to the 2024 Urologic Diseases in America: Annual Data Report. The condition — defined ...
CLEVELAND, Ohio -- The Cleveland Clinic said it recently became the first hospital to use a new wireless, catheter-free device for monitoring bladder function called the Glean Urodynamics System. This ...
When her patient insisted on receiving Botox bladder injections in the operating room (OR), Anne Pelletier Cameron, MD, asked her why. The patient acknowledged her last time receiving the injections ...
A NEW UK-based clinical trial has found that urodynamic testing, a diagnostic tool commonly used before invasive treatments for overactive bladder, may not improve outcomes or represent good value for ...
Dr. Jason Kim and Dr. Steven Weissbart of the Women’s Pelvic Health and Continence Center at Stony Brook University Hospital (SBUH) have successfully performed one of the nation’s first—and the East ...
To discuss the use of urodynamic testing for female stress urinary incontinence and provide a narrative review of the current evidence regarding the utility of urodynamics across the spectrum of ...
Bright Uro Inc. this month received Food and Drug Administration approval for its first product, the Glean Urodynamics System. It’s the biggest milestone to date for the Irvine medical device maker ...
The researchers tracked nearly 175,000 patients with diabetes who received semaglutide -- the active ingredient in Ozempic and other Novo products -- and the same number of patients with diabetes who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results